[1]
M. Wojtuś, S. Tomaszuk, and K. Wąsik, “Burosumab - new potent treatment for X-linked hypophosphatemia and tumor-induced osteomalacia”, J Educ Health Sport, vol. 23, no. 1, pp. 86–94, Jul. 2023.